The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II α, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer.
 
Yen-Shen Lu
Honoraria - GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Boehringer Ingelheim; GlaxoSmithKline; Novartis
Speakers' Bureau - Novartis
Research Funding - GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche Pharma AG
 
Dah-Cherng Yeh
No Relationships to Disclose
 
Ling-Ming Tseng
No Relationships to Disclose
 
Shou-Tung Chen
No Relationships to Disclose
 
Huang-Chun Lien
No Relationships to Disclose
 
Hong-Tai Chang
No Relationships to Disclose
 
Yuan-Ching Chang
No Relationships to Disclose
 
Shu-Min Huang
No Relationships to Disclose
 
Ching-Hung Lin
No Relationships to Disclose
 
Ann-Lii Cheng
No Relationships to Disclose
 
Chiun-Sheng Huang
No Relationships to Disclose